Healthcare Distribution Market
Healthcare Distribution Market Size, Share & Trends Analysis Report by Type (Pharmaceutical Product Distribution Services, Biopharmaceutical Product Distribution Services, Medical Device Distribution Services), by End User (Retail Pharmacies, Hospital Pharmacies, Other), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
|Forecast Years for Healthcare Distribution Market:||2022 - 2028|
|Historical Years for Healthcare Distribution Market:||2016 - 2021|
|Revenue 2021 for Healthcare Distribution Market:||USD 758.5 Billion|
|Revenue 2028 for Healthcare Distribution:||USD 1088.1 Billion|
|Revenue CAGR (2022 - 2028) for Healthcare Distribution Market :||6.2%|
|Fastest Growing Region (2022 - 2028) for Healthcare Distribution Market:||Asia Pacific|
|Largest Region (2021) for Healthcare Distribution Market:||North America|
The Global Healthcare Distribution Market was valued at USD 758.5 Billion in the year 2021 and is projected to reach a value of USD 1088.1 Billion by the year 2028. The Global Market is anticipated to grow to exhibit a Compound Annual Growth Rate (CAGR) of 6.2% over the forecast period.
Healthcare Distribution encompasses all distribution procedures used in the healthcare business to complete activities such as procuring medical, laboratory, and pharmacy supplies, customer relationship management (CRM), ERP support, and information management. It encompasses many businesses, including pharmaceutical wholesalers, distribution, and related services. The Healthcare Distribution sector is undergoing several changes, including prime vendors, customer focus, and genuine distribution partnerships, to name a few.
The top vendors assist end-users in various ways, including simplifying orders, offering simple access to items and product alternatives during back orders, and lowering supply chain costs. In addition, customer focus is a new trend in the market that concentrates on the customers' and distributors' business growth and success. Furthermore, true distribution partnerships in which healthcare professionals seek trusted advisors who respect and collaborate in the hard work that they perform for their communities, patients, and teams.
The Healthcare Distribution Market is segmented based on Type, End-User, and Region. Based on the segment Type, the market is further sub-segmented as Pharmaceutical Product Distribution Services, Biopharmaceutical Product Distribution Services, and Medical Device Distribution Services. Based on End-User segment, the market is further sub-segmented as Retail Pharmacies, Hospital Pharmacies, and Other End Users (Clinical Laboratories, Physician Offices, Home Care Settings, Online Pharmacies, and Long-Term Care Facilities)
Based on Type:
The Pharmaceutical Product Distribution services sub-segment accounted for the maximum market share due to rising pharmaceutical formulation production, increasing pharmaceutical expenditure, manufacturing outsourcing to Asian countries, and global pharmaceutical giants. This growth, in turn, is establishing new manufacturing facilities in more contemporary geographies. Other considerations Favorable investments in research and development activities for manufacturing pharmaceutical goods fuel the growth of Healthcare Distribution services. Furthermore, pharmaceutical distributors are increasingly implementing emerging technologies such as Artificial Intelligence (AI), robotics, and Blockchain to reduce warehouse operational costs & human error and improve supply chain transparency. Therefore it is expected to fuel the growth of Healthcare Distribution services.
Based on End User:
The Retail Pharmacies sub-category accounted for the largest share of the market. These pharmacies deal with a large number of prescriptions daily. Furthermore, measures to ensure that inhabitants in the United States and other developed countries have access to affordable healthcare have significantly increased medicines at retail pharmacies. Increased government efforts to cut healthcare costs have increased considerably the number of prescriptions reaching retail pharmacies. This is expected to continue to drive the segment's revenue growth during the forecast period. In addition, retail pharmacies see a rise in demand due to the changing trend toward more economical generic medications. Throughout the projection period, government actions to develop and maintain standards in the retail pharmacy market will likely promote the retail pharmacy segment's growth.
North America is projected to Grow at the Highest CAGR During the Forecast Period
North America dominated the regional Healthcare Distribution Market in 2020, owing to its better existence in the healthcare sector and rapid adoption of new and advanced technologies. The market is expected to maintain its dominance during the forecast period, owing to its continued engagement and growth in the healthcare sector. By developing initiatives to ensure people have access to health care, the United States has dramatically increased due to the number of prescriptions at retail pharmacies. Distributors have also turned to modern industrial technologies such as artificial intelligence (AI) and machine learning to influence massive data and standardize progressions. The demand for effective supply chain management has become more apparent. This area has enhanced predictability, supply optimization, and waste and expenditure reduction.
The key players in the Global Healthcare Distribution Market include- McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor Inc. (US), Morris Dickson Co., LLC (US), KeySource Medical, Inc. (US), Rochester Drug Cooperative, Inc. (US), Henry Schein Inc. (US), Smith Drug Company (US), FFF Enterprises (US), Patterson Companies Inc. (US), Mutual Drug (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Medline Industries (US), PHOENIX Group (Germany), CuraScript SD (US)., and others.
Segmentation of the Global Healthcare Distribution Market:
Regions & Countries Covered
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Frequently Asked Questions
the global demand for Healthcare Distribution
in terms of revenue?
The global Healthcare Distribution valued at USD 758.5 Billion in 2020 and is expected to reach USD 1088.1 Billion in 2028 growing at a CAGR of 6.2%
are the prominent players
in the market?
The prominent players in the market are McKesson Corporation (US), AmerisourceBergen Corporation (US), Cardinal Health, Inc. (US), Owens & Minor Inc. (US), Morris Dickson Co., LLC (US), KeySource Medical, Inc. (US), Rochester Drug Cooperative, Inc. (US), Henry Schein Inc. (US), Smith Drug Company (US), FFF Enterprises (US), Patterson Companies Inc. (US), Mutual Drug (US), Shanghai Pharmaceutical Group Co., Ltd. (China), Medline Industries (US), PHOENIX Group (Germany), CuraScript SD (US)..
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 6.2% between 2021 and 2028.
the driving factors
fueling the growth of the market.
The driving factors of the Healthcare Distribution include
- Increasing prevalence of chronic diseases
region accounted for the
largest share in the market?
North America was the leading regional segment of the Healthcare Distribution in 2020.